Immupharma PLC Posting of Annual Report and AGM Notice (8431C)

TIDMIMM

RNS Number : 8431C

Immupharma PLC

22 April 2013

FOR IMMEDIATE RELEASE

London, 22 April 2013

Annual Report and Accounts

Notice of Annual General Meeting: 23 May 2013

ImmuPharma PLC (AIM:IMM) (the "Company") the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2012 has been posted to shareholders.

The Annual Report is available, in electronic form, for download on the Company's website www.immupharma.com.

The Company's Annual General Meeting will be held on 23 May 2013 at 11:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.

For further information please contact:

ImmuPharma PLC

   Richard Warr, Chairman                                             +44 20 7152 4080 
   Dimitri Dimitriou, Chief Executive Officer                 +44 20 7152 4080 
   Lisa Baderoon, Head of Investor Relations               +44 7721 413 496 
   Panmure Gordon & Co., NOMAD & Broker                 +44 20 7886 2500

Hugh Morgan, Fred Walsh, Hannah Woodley

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACSSEWFFFFDSEDL

Immupharma (LSE:IMM)
Historical Stock Chart
From Aug 2024 to Sep 2024